In addition, breast cancer is a well-known human malignancy that can express hormone receptors and grow under their influence, as well as its successful story in the era of targeted therapy of human oncology, that is, anti-HER2 immunotherapy. This evidence concerns the gene ERBB2 and breast cancer.